Quick Answer
AVANOS MEDICAL, INC. reported Cash and Equivalents of $89.80 million for fiscal year 2025.
AVANOS MEDICAL, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $89.80M | -16.6% |
| 2024 | $107.70M | +22.8% |
| 2023 | $87.70M | -31.3% |
| 2022 | $127.70M | +7.8% |
| 2021 | $118.50M | +6.3% |
| 2020 | $111.50M | -45.7% |
| 2019 | $205.30M | -46.6% |
| 2018 | $384.50M | +75.0% |
| 2017 | $219.70M | +93.2% |
| 2016 | $113.70M | -12.2% |
| 2015 | $129.50M | -13.1% |
| 2014 | $149.00M | +237.9% |
| 2013 | $44.10M | -7.9% |
| 2012 | $47.90M | +138.3% |
| 2011 | $20.10M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $70.50M | -20.8% | -21.9% |
| June 30, 2025 | $90.30M | -2.1% | -6.9% |
| March 31, 2025 | $97.00M | +28.0% | -9.9% |
| December 31, 2024 | $107.70M | +22.8% | +21.0% |
| September 30, 2024 | $89.00M | -16.9% | -3.5% |
| June 30, 2024 | $92.20M | +12.7% | +21.6% |
| March 31, 2024 | $75.80M | -20.8% | -13.6% |
| December 31, 2023 | $87.70M | -31.3% | -18.1% |
- AVANOS MEDICAL, INC. showed a decrease of -16.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2011–2025 period, AVANOS MEDICAL, INC.’s cash and equivalents has grown by 346.8% (from $20.10 million to $89.80 million).
- The most recent figure is from AVANOS MEDICAL, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: